Please click here to download document in PDF format…
Medical Department
Eastern Railway Hospital, Liluah
EOI No. MED/LLH/10/CASHLESS/02 Dated: 06.02.2020
Expression of Interest
EOI ( Expression of Interest ) invited towards entering into tie-up with NABL and Non NABL Private Laboratories / Diagnostic centers for Laboratory investigations of Railway Beneficiaries of Eastern Railway Hospital, Liluah at prevailing latest CGHS rate through MOU (Memorandum of Undertaking) on Bill Payment system for Inter Lab Testing and backup laboratory work during emergencies as well as for laboratory investigations not being done in-house in Liluah Railway Hospital.
Chief Medical Superintendent, Eastern Railway Hospital, Liluah invites Expression of Interest (EOI) from all the willing Private Laboratories / Diagnostic centers located in and around Howrah for entering into tie-up of railway beneficiaries catered by Liluah Railway Hospital.
EOI document & format is to be collected from the office of Chief Medical Superintendent, Eastern Railway, Liluah or same may also be downloaded from the website: er.indianrailways.gov.in.
The responses on the prescribed format is to be submitted to the office of Chief Medical Superintendent, Eastern Railway Hospital, Liluah on or before 18.02.2020 (within 12.00 hrs). For any further clarification the authorized person in the Office of Chief Medical Superintendent, Eastern Railway Hospital, Liluah may be contacted ( Contact No. 033-26545386).
-Sd -
Chief Medical Superintendent
Eastern Railway Hospital, Liluah.
Medical Department.
Eastern Railway Hospital, Liluah
Terms and Conditions and Instructions for doing Investigations :
1)Firms/ Diagnostics centers – should have NABL Accreditation OR Non NABL with good reputation and reliable, have proper and updated License, consent to operate and authorization from the Competent Authority Self attested photocopy of related documents shall have to be submitted along with the quotations.
2)Credential – establishment more than five years well equipped (equipments should be of reputed make and not to be more than 5 years) with a good credential.Credentials/ Satisfactory performance if any report shall have to be submitted along with the quotations.
3)Service – 24 × 7 hours service must be available and reasonable waiting time considering urgency of the case.
4)Care of the patient – all necessary care should be taken to carry out the investigations.No refusal to the patient.
5)Reports – should be in proper letter head and duly signed by concerned specialist at the earliest to the concerned Dept./Doctor or to the patient party under clear signature.
6)Any incorrect report leading to wrong diagnosis & management or any kind of infection or disease transmitted to the patient or any damage to the patient during the procedure, the responsibility including payment of legal charges or any sort of compensation to the patient shall have to be borne by the authorized Diagnostic centre.
7)Rates of Investigations – as per with CGHS rates in Kolkata 2014 (attached herewith) as updates from time to time.
8)Mode of payment-Bills to be generated for each patients and payment shall be made on Monthly basis through NEFT/Money Instrument as advised by the Administration.PAN card No. should be mentioned in all bills.Taxes as applicable shall be deducted from the bills as per extent rules.
9)Period of contract – will be for One year from the date of commencement of work and the provision of contract is subject to further extension at the CGHS Kolkata rates and terms and at the sole discretion of Railway Administration.
10)Memorandum of Understanding to be signed before commencement of work.
11)Railway Administration reserves the right to change or modify the period of the contact as per administrative requirement & also to accept or reject any or all the offers without assigning any reason whatsoever.
12)Submission of EOI ( Annexure -A )EOI for doing the investigations (Annexure) duly filled and signed with office seal in a sealed envelope to be submitted to the office of Chief Medical Superintendent, Railway Hospital, Liluah, Eastern Railway P.O Liluah, P.S Belur, Dist. Howrah, Pin 711204 on working days between 11.00 hrs. to 16.00 hrs. (Monday to Friday) and 11.00 hrs. to 13.00 hrs on Saturday (except holidays)
from 14 .02.2020to 12.00 hrs. of 18.02.2020.
13)Inspection of the Diagnostics centers by medical team of Railway Hospital , Liluah, shall be done prior to finalization and offer of contract.
14)Signatures and office seal must be on the pages of terms and conditions and respective annexure.
15)Notice: Railway shall be entitled to terminate the contact at any time by giving one month notice in writing. A prior notice of one(01) month in writing has to be given by the offerer for discontinuation of work.
Eligibility Criteria :
1.Diagnostic centres should (NABL Accreditation or Non-NABL) with good reputation & reliable.
2.Should have all proper Licenses from the competent authority to operate.
3.Establishment : Should have at least five years well equipped with a good credential.
4.24 × 7 hours service must be available.
5.No refusal to the patients.
Addl. Chief Medical SuperintendentSignature/s of the Proprietor/s
Diagnostic Center
Eastern Railway Hospital, Liluah.
Rly .Ph.: - 25105
Tel. No : 033-2654-5386Name (s) in full ________________________________
Name of the Firm ____________________________
Full Postal address_____________________________
Dist._______ P.S. _______________Pin _____________
Tel. No. _________________Fax___________________
Mobile no _____________________________________
E-mail ________________________________________
Date ____/_____/_______
Office Seal
Chief Medical Superintendent, Eastern Railway, Hospital, Liluah.
EOI No. – H/Cashless/LLHDated : 06.02.2020
Name of work :Different investigation of Eastern Railway Hospital.
Schedule of work : As per terms and conditions.
ANNEXURE – A
Sl. No | CGHS SL.No | NAMEOF INVESTIGATION | CGHS RATES (Non NABL) (Rs.) | CGHS RATES (NABL) (Rs.) | Rate Quoted by the firm |
1 | 9 | Pericardial Aspiration | 380 | 437 | |
2 | 10 | Joints Aspiration | 317 | 365 | |
3 | 11 | Biopsy skin | 230 | 265 | |
4 | 381 | Trucut needle biopsy | 1395 | 1604 | |
5 | 382 | Percutaneous Kidney Biopsy | 1470 | 1691 | |
6 | 384 | Muscle biopsy | 1470 | 1691 | |
7 | 406 | Gastroscopy | 1725 | 1984 | |
8 | 407 | Gastric & Duodenal Biopsy | 1755 | 2018 | |
9 | 566 | Diagnostic Electrophysiological Studies Conventional | 4550 | 5233 | |
10 | 567 | Ambulatory BP Monitoring | 587 | 675 | |
11 | 579 | C.T guided biopsy | 1139 | 1310 | |
12 | 586 | Holter analysis | 850 | 978 | |
13 | 591 | HUTT | 2200 | 2530 | |
14 | 592 | 2 D echocardiography | 1080 | 1242 | |
15 | 595 | 2 D TEE | 1403 | 1613 | |
16 | 597 | Stress Echo – exercise | 1500 | 1725 | |
17 | 598 | Stress echo - pharmacological | 2500 | 2875 | |
18 | 599 | Stress MPI – exercise | 1955 | 2248 | |
19 | 600 | Stress MPI – pharmacological | 2500 | 2875 | |
20 | 602 | CT coronary angiography | 6030 | 6935 | |
21 | 604 | Cardiac MRI | 2444 | 2811 | |
22 | 606 | MR angiography | 5635 | 6480 | |
23 | 822 | Arteriovenous Fistula for haemodialysis | 2300 | 2645 | |
24 | 842 | Ultrasound guided kidney Biopsy | 850 | 978 | |
25 | 889 | Uroflow study | 450 | 518 | |
26 | 894 | Voiding–cysto –urethrogram and retrograde urethrogram(nephrostogram) | 414 | 476 | |
27 | 939 | Nerve Biopsy | 6210 | 7142 | |
28 | 1281 | Upper G.I. Endoscopy + Lower G.I. Endoscopy | 1725 | 1984 | |
29 | 1297 | Double balloon enteroscopy | 3500 | 4025 | |
30 | 1316 | Ultrasound guided FNAC | 575 | 661 | |
31 | 1317 | Ultrasound guided abscess Drainage | 720 | 828 | |
32 | 1335 | Fecal fat test/fecal chymotrypsin/ fecal elastase | 350 | 403 | |
33 | 1336 | Breath tests | 300 | 345 | |
34 | 1338 | Liver biopsy | 1380 | 1587 | |
35 | 1341 | OPG X-ray | 176 | 202 | |
36 | 1344 | Whole body bone scan with SPECT | 3079 | 3541 | |
37 | 1357 | Dynamic renography with captopril | 1960 | 2254 | |
38 | 1360 | Thyroid scan with technetium 99m pertechnetate | 1319 | 1517 | |
39 | 1375 | TMT | 440 | 506 | |
40 | 1376 | TEE | 440 | 506 | |
41 | 1388 | Serum analysis | 35 | 40 | |
42 | 1396 | Reticulocyte count | 43 | 49 | |
43 | 1397 | Absolute eosinophil count | 43 | 49 | |
44 | 1402 | Osmotic fragility test | 50 | 58 | |
45 | 1403 | Bone marrow smear examination | 64 | 74 | |
46 | 1404 | Bone marrow smear examination with iron stain | 225 | 259 | |
47 | 1405 | Bone marrow smear examination & cytochemistry | 396 | 455 | |
48 | 1406 | Activated partial thromboplastin time | 92 | 106 | |
49 | 1408 | WBC cytochemistry for leukemia – complete panel | 110 | 127 | |
50 | 1409 | Bleeding disorder panel – PT, APTT, Thrombin time fibrinogen, D-Dimer/FDP | 360 | 414 | |
51 | 1410 | Factor assays-factor VIII | 648 | 745 | |
52 | 1411 | Factor assays-factorIX | 612 | 704 | |
53 | 1412 | Platelet function test | 50 | 58 | |
54 | 1413 | Tests for hypercoagulable states- Protein C, Protein S, Antithrombin | 400 | 460 | |
55 | 1414 | Tests for lupus anticoagulant | 150 | 173 | |
56 | 1415 | Teste for antiphospholipid antibody IgG, IgM (for cardiolipin and B2 Glycoprotein 1) | 450 | 518 | |
57 | 1416 | Thalassemia studies(Red Cell indices and HB HPLC) | 560 | 644 | |
58 | 1417 | Testes for sickling/(HB HPLC) | 69 | 79 | |
59 | 1420 | Coomb’s test- direct | 81 | 93 | |
60 | 1421 | Coomb’s test- Indirect | 90 | 104 | |
61 | 1422 | 3 cell panel-antibody screening for pregnant female | 170 | 196 | |
62 | 1428 | RH antibody titer | 80 | 92 | |
63 | 1432 | Routine – H & E | 85 | 98 | |
64 | 1433 | Special stain | 65 | 75 | |
65 | 1438 | Body fluid for malignant cells | 150 | 173 | |
66 | 1439 | FNAC | 200 | 230 | |
67 | 1440 | Leukemia panel / lymphoma panel | 1536 | 1766 | |
68 | 1441 | PNH panel- CD55, CD59 | 1000 | 1150 | |
69 | 1442 | karyotyping | 1539 | 1770 | |
70 | 1443 | FISH | 500 | 575 | |
71 | 1456 | Serum Bilirubin total & direct | 80 | 92 | |
72 | 1457 | Serum iron | 85 | 98 | |
73 | 1464 | Total iron binding capacity | 80 | 92 | |
74 | 1468 | Serum phosphorus | 56 | 64 | |
75 | 1472 | IgA | 225 | 259 | |
76 | 1473 | ANA | 200 | 230 | |
77 | 1474 | Ds DNA | 327 | 376 | |
78 | 1478 | Serum Lipase | 130 | 150 | |
79 | 1479 | Serum lactate | 72 | 83 | |
80 | 1480 | Serum magnesium | 100 | 115 | |
81 | 1481 | Serum sodium | 50 | 58 | |
82 | 1482 | Serum potassium | 50 | 58 | |
83 | 1483 | Serum Ammonia | 100 | 115 | |
84 | 1485 | Serum testosterone | 150 | 173 | |
85 | 1488 | Glucose tolerance test (GTT) | 85 | 98 | |
86 | 1489 | Triple marker | 765 | 880 | |
87 | 1491 | Foetal Haemoglobin (HbF) | 85 | 98 | |
88 | 1493 | L.D.H. | 100 | 115 | |
89 | 1495 | Acid phosphatase | 70 | 81 | |
90 | 1500 | Glucose phosphate dehydrogenase(G, 6PD) | 100 | 115 | |
91 | 1501 | Lithium | 119 | 137 | |
92 | 1502 | Dilantin (phenytoin) | 373 | 429 | |
93 | 1503 | Carbamazepine | 373 | 429 | |
94 | 1504 | Valproic acid | 270 | 311 | |
95 | 1505 | Feritin | 250 | 288 | |
96 | 1506 | Blood gas analysis | 120 | 138 | |
97 | 1507 | Blood gas analysis with electrolytes | 414 | 476 | |
98 | 1509 | Tests for antiphospholipid antibodies syndrome | 280 | 322 | |
99 | 1511 | HB Electrophoresis/HB HPLC | 100 | 115 | |
100 | 1516 | Total iron binding capacity | 85 | 98 | |
101 | 1518 | Vitamin B12 assay | 225 | 259 | |
102 | 1519 | Folic acid assay | 298 | 343 | |
103 | 1520 | Extended lipid profile. (Total cholesterol, LDL , HDL treigylcerides. Apo A1, Apo B,Lp (a)) | 595 | 684 | |
104 | 1521 | Apo A1. | 180 | 207 | |
105 | 1522 | Apo B. | 179 | 206 | |
106 | 1523 | Lp (a). | 401 | 461 | |
107 | 1524 | CD 3,4 and 8 counts | 170 | 196 | |
108 | 1525 | CD 3,4 and 8 percentage | 170 | 196 | |
109 | 1526 | LDL | 56 | 64 | |
110 | 1527 | Homocysteine. | 387 | 445 | |
111 | 1528 | HB Electrophoresis. | 396 | 455 | |
112 | 1529 | Serum electrophoresis | 220 | 253 | |
113 | 1530 | fibrinogen | 165 | 190 | |
114 | 1533 | GGTP | 85 | 98 | |
115 | 1534 | Lipase | 215 | 247 | |
116 | 1535 | Fructosamine | 190 | 219 | |
117 | 1536 | β2 microglobulin | 85 | 98 | |
118 | 1537 | Catecholamines | 945 | 1087 | |
119 | 1538 | Creatinine clearance | 108 | 124 | |
120 | 1539 | PSA - total | 281 | 323 | |
121 | 1540 | PSA - free | 375 | 431 | |
122 | 1541 | AFP | 270 | 311 | |
123 | 1542 | HCG | 260 | 299 | |
124 | 1543 | CA. 125 | 352 | 405 | |
125 | 1544 | CA 19,9 | 554 | 637 | |
126 | 1545 | CA 15.3 | 536 | 616 | |
127 | 1546 | Vinyl Mandelic Acid | 350 | 403 | |
128 | 1547 | Calcitonin | 500 | 575 | |
129 | 1548 | Carcioembryonic antigen (CEA) | 306 | 352 | |
130 | 1549 | Immunofluorescence | 150 | 173 | |
131 | 1551 | Indirect (antides DNA Anti Smith ANCA) | 383 | 440 | |
132 | 1552 | Vit. D3 assay | 550 | 633 | |
133 | 1553 | Serum protin electrophoresis with immunofixationelectrophoresis (IFE) | 270 | 311 | |
134 | 1554 | BETA 2 Microglobulin assay | 90 | 104 | |
135 | 1555 | Anti cycliocitrullinated peptide (Anti CCP) | 425 | 489 | |
136 | 1556 | Anti tissuetransglutaminase antibody | 425 | 489 | |
137 | 1557 | Serum erythropoietin | 425 | 489 | |
138 | 1558 | ACTH | 500 | 575 | |
139 | 1559 | T3, T4, TSH | 181 | 208 | |
140 | 1560 | T3 | 64 | 74 | |
141 | 1561 | T4 | 64 | 74 | |
142 | 1562 | TSH | 90 | 104 | |
143 | 1563 | LH | 150 | 173 | |
144 | 1564 | FSH | 150 | 173 | |
145 | 1565 | Prolactin | 150 | 173 | |
146 | 1566 | Cortisol | 226 | 260 | |
147 | 1567 | PTH (Paratharmone) | 500 | 575 | |
148 | 1568 | C-Peptide | 330 | 380 | |
149 | 1569 | Insulin | 150 | 173 | |
150 | 1570 | Progesterone | 225 | 259 | |
151 | 1571 | 17 – DH Progesterone | 396 | 455 | |
152 | 1572 | DHEAS | 396 | 455 | |
153 | 1573 | Androstendione | 600 | 690 | |
154 | 1574 | Growth Hormone | 306 | 352 | |
155 | 1575 | TPO | 300 | 345 | |
156 | 1576 | Throglobulin | 300 | 345 | |
157 | 1577 | Hydatic Serology | 318 | 366 | |
158 | 1578 | Anti Sperm antibodies | 345 | 397 | |
159 | 1582 | HPV serology | 218 | 251 | |
160 | 1583 | Rota Virus serology | 130 | 150 | |
161 | 1584 | PCR for TB | 829 | 953 | |
162 | 1585 | PCR for HIV | 540 | 621 | |
163 | 1586 | Chlamydae antigen | 765 | 880 | |
164 | 1587 | Chlamydae antibody | 238 | 274 | |
165 | 1588 | Brucella serology | 208 | 239 | |
166 | 1589 | Influenza A serology | 849 | 976 | |
167 | 1599 | Carotid doppler | 850 | 978 | |
168 | 1602 | Colour Doppler, renal arteries/any other organ | 800 | 920 | |
169 | 1603 | USG guided intervention - FNAC | 490 | 564 | |
170 | 1604 | USG guided intervention - biopsy | 720 | 828 | |
171 | 1624 | ERCP(endoscopic retrograde cholangio - pancreatography) | 2500 | 2875 | |
172 | 1627 | Intravenous pyelography (IVP) | 1071 | 1232 | |
173 | 1628 | Micturating cystourethrography (MCU) | 680 | 782 | |
174 | 1635 | X-ray mammography | 315 | 362 | |
175 | 1658 | C.T guided intervention – FNAC | 1080 | 1242 | |
176 | 1659 | C.T guided trucut Biopsy | 1200 | 1380 | |
177 | 1714 | Dexa scan bone densitometry – three sites(Spinr,Hip & Extremity) | 1955 | 2248 | |
178 | 1717 | EMG (Electro Myography) | 574 | 660 | |
179 | 1718 | Nerve condition velocity | 638 | 734 | |
180 | 1722 | Poly somnography | 638 | 734 | |
181 | 1728 | Serum ceruloplasmin | 450 | 518 | |
182 | 1729 | Urinary copper | 450 | 518 | |
183 | 1731 | Serum valproate level | 315 | 362 | |
184 | 1738 | PCR for tuberculosis/Herpes simplex | 1080 | 1242 | |
185 | 1740 | Mycobacterial culture & sensitivity | 180 | 207 | |
186 | 1741 | Fungal culture | 128 | 147 | |
187 | 1743 | Anti measles antibody titre | 890 | 1024 | |
188 | 1744 | Viral culture | 255 | 293 | |
189 | 1747 | Myelin basic protein | 1871 | 2152 | |
190 | 1749 | Crypto coccal antigen | 1024 | 1178 | |
191 | 1756 | Urinary VMA | 1350 | 1553 |
|